Clinical Trial Update: OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study of OC000459 in patients with asthma has completed enrollment; the provided information does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• OC000459

Snippet

Sponsor: Oxagen Ltd | Conditions: Mild to Moderate Persistent Asthma | Phase 2 | Status: COMPLETED